vs
Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and Solventum (SOLV). Click either name above to swap in a different company.
Solventum is the larger business by last-quarter revenue ($2.0B vs $1.0B, roughly 2.0× Everus Construction Group, Inc.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs 0.6%, a 4.8% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -3.0%). Everus Construction Group, Inc. produced more free cash flow last quarter ($23.5M vs $-273.0M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs -1.8%).
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
ECG vs SOLV — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $2.0B |
| Net Profit | $55.3M | $13.0M |
| Gross Margin | 11.6% | 54.7% |
| Operating Margin | 6.8% | 4.0% |
| Net Margin | 5.5% | 0.6% |
| Revenue YoY | 33.2% | -3.0% |
| Net Profit YoY | 60.4% | — |
| EPS (diluted) | $1.09 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.0B | ||
| Q4 25 | $1.0B | $2.0B | ||
| Q3 25 | $986.8M | $2.1B | ||
| Q2 25 | $921.5M | $2.2B | ||
| Q1 25 | $826.6M | $2.1B | ||
| Q4 24 | $759.6M | $2.1B | ||
| Q3 24 | $761.0M | $2.1B | ||
| Q2 24 | $703.4M | $2.1B |
| Q1 26 | — | $13.0M | ||
| Q4 25 | $55.3M | $63.0M | ||
| Q3 25 | $57.0M | $1.3B | ||
| Q2 25 | $52.8M | $90.0M | ||
| Q1 25 | $36.7M | $137.0M | ||
| Q4 24 | $34.5M | $31.0M | ||
| Q3 24 | $41.8M | $122.0M | ||
| Q2 24 | $39.0M | $89.0M |
| Q1 26 | — | 54.7% | ||
| Q4 25 | 11.6% | 51.4% | ||
| Q3 25 | 12.6% | 54.2% | ||
| Q2 25 | 13.0% | 54.4% | ||
| Q1 25 | 11.2% | 53.8% | ||
| Q4 24 | 11.4% | 53.9% | ||
| Q3 24 | 11.8% | 56.0% | ||
| Q2 24 | 12.6% | 54.6% |
| Q1 26 | — | 4.0% | ||
| Q4 25 | 6.8% | 6.3% | ||
| Q3 25 | 7.3% | 80.6% | ||
| Q2 25 | 7.9% | 9.9% | ||
| Q1 25 | 6.2% | 7.3% | ||
| Q4 24 | 6.1% | 6.6% | ||
| Q3 24 | 7.1% | 13.2% | ||
| Q2 24 | 7.3% | 11.7% |
| Q1 26 | — | 0.6% | ||
| Q4 25 | 5.5% | 3.2% | ||
| Q3 25 | 5.8% | 60.4% | ||
| Q2 25 | 5.7% | 4.2% | ||
| Q1 25 | 4.4% | 6.6% | ||
| Q4 24 | 4.5% | 1.5% | ||
| Q3 24 | 5.5% | 5.9% | ||
| Q2 24 | 5.5% | 4.3% |
| Q1 26 | — | $0.07 | ||
| Q4 25 | $1.09 | $0.37 | ||
| Q3 25 | $1.11 | $7.22 | ||
| Q2 25 | $1.03 | $0.51 | ||
| Q1 25 | $0.72 | $0.78 | ||
| Q4 24 | $0.68 | $0.18 | ||
| Q3 24 | $0.82 | $0.70 | ||
| Q2 24 | $0.76 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $561.0M |
| Total DebtLower is stronger | $281.5M | $4.6B |
| Stockholders' EquityBook value | $629.8M | $5.0B |
| Total Assets | $1.7B | $14.1B |
| Debt / EquityLower = less leverage | 0.45× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $561.0M | ||
| Q4 25 | — | $878.0M | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | $492.0M | ||
| Q1 25 | — | $534.0M | ||
| Q4 24 | — | $762.0M | ||
| Q3 24 | $553.0K | $772.0M | ||
| Q2 24 | — | $897.0M |
| Q1 26 | — | $4.6B | ||
| Q4 25 | $281.5M | $5.0B | ||
| Q3 25 | $285.1M | $5.1B | ||
| Q2 25 | $288.6M | $7.8B | ||
| Q1 25 | $292.1M | $7.9B | ||
| Q4 24 | $295.6M | $8.0B | ||
| Q3 24 | — | $8.1B | ||
| Q2 24 | — | $8.3B |
| Q1 26 | — | $5.0B | ||
| Q4 25 | $629.8M | $5.0B | ||
| Q3 25 | $573.0M | $5.0B | ||
| Q2 25 | $514.4M | $3.6B | ||
| Q1 25 | $460.2M | $3.3B | ||
| Q4 24 | $422.6M | $3.0B | ||
| Q3 24 | $453.3M | $3.2B | ||
| Q2 24 | $490.0M | $2.9B |
| Q1 26 | — | $14.1B | ||
| Q4 25 | $1.7B | $14.3B | ||
| Q3 25 | $1.6B | $14.0B | ||
| Q2 25 | $1.5B | $15.1B | ||
| Q1 25 | $1.4B | $14.5B | ||
| Q4 24 | $1.3B | $14.5B | ||
| Q3 24 | $1.3B | $14.7B | ||
| Q2 24 | — | $14.6B |
| Q1 26 | — | 0.92× | ||
| Q4 25 | 0.45× | 1.00× | ||
| Q3 25 | 0.50× | 1.03× | ||
| Q2 25 | 0.56× | 2.14× | ||
| Q1 25 | 0.63× | 2.43× | ||
| Q4 24 | 0.70× | 2.71× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 2.90× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $48.2M | — |
| Free Cash FlowOCF − Capex | $23.5M | $-273.0M |
| FCF MarginFCF / Revenue | 2.3% | -13.6% |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | 0.87× | — |
| TTM Free Cash FlowTrailing 4 quarters | $90.0M | $-203.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $48.2M | $95.0M | ||
| Q3 25 | $76.2M | $76.0M | ||
| Q2 25 | $25.3M | $169.0M | ||
| Q1 25 | $7.1M | $29.0M | ||
| Q4 24 | — | $219.0M | ||
| Q3 24 | $78.9M | $169.0M | ||
| Q2 24 | — | $355.0M |
| Q1 26 | — | $-273.0M | ||
| Q4 25 | $23.5M | $32.0M | ||
| Q3 25 | $65.7M | $-21.0M | ||
| Q2 25 | $12.3M | $59.0M | ||
| Q1 25 | $-11.4M | $-80.0M | ||
| Q4 24 | — | $92.0M | ||
| Q3 24 | $60.9M | $76.0M | ||
| Q2 24 | — | $297.0M |
| Q1 26 | — | -13.6% | ||
| Q4 25 | 2.3% | 1.6% | ||
| Q3 25 | 6.7% | -1.0% | ||
| Q2 25 | 1.3% | 2.7% | ||
| Q1 25 | -1.4% | -3.9% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | 8.0% | 3.7% | ||
| Q2 24 | — | 14.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 3.2% | ||
| Q3 25 | 1.1% | 4.6% | ||
| Q2 25 | 1.4% | 5.1% | ||
| Q1 25 | 2.2% | 5.3% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | 2.4% | 4.5% | ||
| Q2 24 | — | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.87× | 1.51× | ||
| Q3 25 | 1.34× | 0.06× | ||
| Q2 25 | 0.48× | 1.88× | ||
| Q1 25 | 0.19× | 0.21× | ||
| Q4 24 | — | 7.06× | ||
| Q3 24 | 1.89× | 1.39× | ||
| Q2 24 | — | 3.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ECG
| Commercial | $594.5M | 59% |
| Utility | $203.5M | 20% |
| Industrial | $82.8M | 8% |
| Institutional | $66.1M | 7% |
| Service And Other | $28.4M | 3% |
| Transportation | $24.2M | 2% |
| Renewables | $19.8M | 2% |
SOLV
| Infection Prevention and Surgical Solutions | $737.0M | 37% |
| Advanced Wound Care | $497.0M | 25% |
| Dental Solutions | $354.0M | 18% |
| Health Information Systems | $342.0M | 17% |
| All Other 4 | $76.0M | 4% |
